InSitu Biologics is an emerging biotech company focused on the development of a multi-phase prolonged-release drug delivery platform for localized treatment of pain, cancer, and infection.

Pharmaceutical

InSitu Biologics

InSitu Biologics' headquarters in Woodbury, MN, United States

Bill Taylor

Kevin Barrett

Stefano M. Sinicropi

Mark Ereth

Dr. Daniel P. Sipple

Kelsey P.

Buzz Benson

Andy LaFrence

James Knapp

Robert Wilson

The Leadership Team at InSitu Biologics is responsible for guiding the company's strategic vision and overseeing the development of innovative drug delivery solutions. This team, comprising top executives including the CEO, CSO, COO, and CMO, collaborates to drive research initiatives, ensure operational efficiency, and foster partnerships that enhance the company's mission to improve localized treatment for pain, cancer, and infection. They play a crucial role in aligning the company’s goals with regulatory standards and market needs.

Leadership Team

The Clinical Operations Team at InSitu Biologics oversees the planning, execution, and management of clinical trials. They ensure compliance with regulatory requirements, monitor patient safety, and coordinate with research sites to gather accurate data for the development of the company’s prolonged-release drug delivery platform.

Clinical Operations Team

The Science and Research team at InSitu Biologics is responsible for pioneering and optimizing the multi-phase prolonged-release drug delivery platform. This team conducts rigorous scientific studies, clinical trials, and collaborates on the development of innovative treatments targeting pain, cancer, and infection, ensuring the efficacy and safety of the company's biotechnological advancements.

InSitu Biologics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations Team

Science and Research

Offices

InSitu Biologics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations Team

Science and Research

Offices

Related companies